Excellence in Research Award

About the Award

Each year the ASGCT Abstract Review Committee selects 15 top abstracts submitted by students and fellows to receive Excellence in Research Awards. Recipients of the Excellence in Research Awards are announced during the George Stamatoyannopoulos Memorial Lecture at the ASGCT Annual Meeting and receive a monetary award of $500 along with a plaque.

Criteria and Selection

Any ASGCT member or associate member who submits an abstract to the Annual Meeting is eligible to receive the award.



Martina Fiumara
Uncovering Upsides and Pitfalls of Base and Prime Editing in Hematopoietic Stem Cells

Alan Rosales
Evolving Nephrotropic AAV Variants Using Ex Vivo NHP Kidney Perfusion and Human Kidney Organoids

William Feist
Establishing Multilayered Genetic Resistance to HIV-1 By Engineering Hematopoietic Stem and Progenitor Cells for B Cell Specific Secretion of Therapeutic Antibodies

Cesare Canepari
Improving The Efficiency Of In Vivo Lentiviral Gene Transfer To Hepatocytes, By Targeting Anti-Viral Pathways, And Application To Familial Hypercholesterolemia

Chun Huang
Genome editing B cells to express custom Heavy chain antibodies with modified antigen specificity and Fc function

Royce Ma
CD5 CAR T-cells promote selection of fratricide-resistant circulating T-cells thus avoiding global T-cell aplasia

Timothy Smith
Newly engineered IgM and IgG cleaving enzymes for AAV gene therapy

Geoffrey Rogers, PhD
Engineered Human B cells Respond to Antigen-Specific Immunization in a Tonsil Organoid Model

Ai Vu Hong
An Integrin-targeting AAV developed by a novel computational rational design methodology presents an improved targeting to the skeletal muscle and reduced tropism to the liver

Gabriele Casirati
Epitope edited hematopoietic stem cells allow immune-based in vivo selection of genome-engineered cells

Junping Zhang, PhD
A new cceAAV vector without a mutant ITR is efficient for reducing subgenome generation

Nadja Meumann
In vivo targeting of HSCs by capsid-engineered AAV vectors

Cassie Turnage
Subacute Liver Injury In Two Young Infants Following Gene Replacement Therapy For Spinal Muscular Atrophy

Rrita Daci
Development of adeno-associated virus (AAV) vectors for intratumoral gene replacement therapy in a novel mouse model of neurofibromatosis type 1 (NF1)

William Nyberg
An Evolved AAV Variant Enables Efficient Genetic Engineering of Murine T Cells and the Modeling of CAR-T Cells in Immunocompetent Tumor Models


Panagiotis Antoniou, PhD
Base Editing of a γ-globin cis-regulatory Element in Human Hematopoietic Stem Cells for Reactivation of Therapeutic Fetal Hemoglobin

Jacob Aurelien, PhD
The Choice of Template Delivery Mitigates the Genotoxic Risk and Adverse Impact of Editing in Human Hematopoietic Stem Cells

Benjamin Arnson
Genome Editing in a Canine Model for Glycogen Storage Disease Type Ia

Tania Baccega, PhD
A Novel Polyfunctional Editing Strategy for Adoptive T Cell Immunotherapy of Cancer

Wassamon Boonying, PhD
Astrocyte-Restricted Gene Silencing Improves the Safety of AAV9-Mediated Gene Therapy for Alexander Disease

Martino Alfredo Cappelluti, PhD
Durable Silencing of Pcsk9 by in vivo Hit-and-run Epigenome Editing

Ting-Yen Chao
Ministring DNA: A Durable and Safe Nonviral Delivery Platform

Amanda Sales Conniff, PhD
DNA Sensor Palmitoylation in Mouse Skeletal Muscle Following DNA Electroporation

Anastasia Conti, PhD
Cellular Senescence and Inflammatory Programs are Unintended Consequences of CRISPR-Cas9 Gene Editing in Hematopoietic Stem and Progenitors Cells

Siddhant Gupte
Development of an AAV-based Gene Therapy for the Ocular Phenotype of Friedreich’s Ataxia

Dalia Haydar, PhD
CD28-based B7-H3 CAR T Cells Have Superior Anti-glioma Efficacy in an Immune Competent Glioma Model While Suppressive Macrophages at Tumor Edges are Associated

Nayan Jain
Disruption of H3K9me3-mediated Gene Silencing Augments CAR T Cell Functional Persistence

Chang Li, PhD
Correction of the Sickle Cell Mutation by In Vivo HSC Prime Editing in a Mouse Model

Feiyan Mo
Engineering T Cells To Prevent Acute Graft-Versus-Host Disease And Leukemia Relapse Following Allogeneic Stem Cell Transplantation

Annita Montepeloso, PhD
Targeting CX3CR1 Gene to Improve Microglia Reconstitution and Transgene Delivery into the CNS Upon Hematopoietic Stem and Progenitor Cell Transplant

Samantha Powers, PhD
A Novel Gene Therapy for Rett Syndrome through Reactivation of the Silent X Chromosome

Huiya Yang
Safe And Efficacious Rescue Of GM3 Synthase Deficiency Mice By Spatially Regulated Gene Delivery

Chi-Yuan Zhang, PhD
A Novel DNA Oligo-based Repair Strategy for the Functional Correction of Shwachman-Diamond Syndrome


Sangya Agarwal
Investigating the Therapeutic Efficacy of Disruption of Cell Intrinsic Checkpoint Regulator CTLA-4 in Chimeric Antigen Receptor T Cells

Antonio Carusillo
Modulation of DNA Repair Pathways by HDR-CRISPR Promotes Seamless Genome Editing in Primary Human Hematopoietic Cells

Yue Du
Vectored Immunoprophylaxis for COVID-19 (COVIP)

Samuele Ferrari
Triggering P53 Activation and Trapping of Transcriptionally Active Recombinant AAV Sequences Are Inadvertent Consequences of HSC Genome Editing

Nayan Jain
CAR Design and Expression Determine Hyper-Proliferative States in TET2 Deficient T Cells

Francesco Manfredi
Exhausted, Tumor-Specific T Cells Can Be Exploited to Generate a Library of T-Cell Receptors for Adoptive T Cell Therapy in Blood Malignancies

Megan Manson
Optimization of Transcutaneous Ultrasound Mediated Gene Delivery into Large Animals

Katharina Meijboom
CRISPR/Cas9-Mediated Excision of ALS/FTD-Causing Hexanucleotide Repeat Expansion in C9ORF72 Rescues Major Disease Mechanisms

Helena Meyer-Berg
Generation of a Human 3D Lung Model for Therapeutic Gene Editing in Surfactant Protein B Deficiency

Alessio Nahmad
In-Vivo Engineered B Cells Retain Memory and Secrete High Titers of Anti-HIV Antibodies in Mice

Eleni Panagioti
Immunostimulatory Bacterial Antigen-Armed Oncolytic Measles Virotherapy Significantly Increases the Potency of Anti-PD1 Checkpoint Therapy

Sandhya Sharma
Memory Enriched Epstein-Barr Virus {EBV} Specific T-Cells with Broader Target Antigen Repertoire for the Treatment of EBV+ Malignancies

Toloo Taghian
Real-Time MR Tracking of AAV Gene Therapy with Enzyme-Activated MR Probes

Maria Vitale
An Oncolytic Adenoviral Vector Expressing an Anti-PD-L1 scFv Reduces Tumor Growth in a Melanoma Mouse Model

Jesse Weber
Capturing and Characterizing Single Cell Allelic Heterogeneity of CRISPR-Cas9 Gene Editing In Vivo


Register for the 27th Annual Meeting

May 7-11, 2024 | Baltimore, MD

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.